If both rapid and genomic pathways may co-exist in the same cell, the involvement of the nuclear vitamin D receptor (VDR) in the rapid effects of 1,25-dihydroxyvitamin D 3 (1,25-(OH) 2 D 3 ) remains unclear. We therefore studied rapid and long term effects of 1,25-(OH) 2 D 3 in cultured skin fibroblasts from three patients with severe vitamin D-resistant rickets and one age-matched control. Patients bear homozygous missense VDR mutations that abolished either VDR binding to DNA (patient 1, mutation K45E) or its stable ligand binding (patients 2 and 3, mutation W286R). In patient 1 cells, 1,25-(OH) 2 D 3 (1 pM-10 nM) had no effect on either intracellular calcium or 24-hydroxylase (enzyme activity and mRNA expression). In contrast, cells bearing the W286R mutation had calcium responses to 1,25-(OH) 2 D 3 (profile and magnitude) and 24-hydroxylase responses to low (1 pM-100 pM) 1,25-(OH) 2 D 3 concentrations (activity, CYP24, and ferredoxin mRNAs) similar to those of controls. The blocker of Ca 2؉ channels, verapamil, impeded both rapid (calcium) and long term (24-hydroxylase activity, CYP24, and ferredoxin mRNAs) responses in patient and control fibroblasts. The MEK 1/2 kinase inhibitor PD98059 also blocked the CYP24 mRNA response. Taken together, these results suggest that 1,25-(OH) 2 D 3 rapid effects require the presence of VDR and control, in part, the first step of 1,25-(OH) 2 D 3 catabolism via increased mRNA expression of the CYP24 and ferredoxin genes in the 24-hydroxylase complex.
The general and severe end organ resistance to vitamin D observed in patients with mutations in the gene encoding the nuclear vitamin D receptor (VDR) 1 bring forth strong evidence that most cellular actions of 1,25-(OH) 2 D 3 , the hormonal form of vitamin D, are mediated through interactions of the hormone with its nuclear receptor (1) . The VDR, which belongs to the steroid/thyroid nuclear receptor family, is composed of two principal domains, one domain for hormone binding (exons 6 -9) and one domain for DNA binding (exons 2 and 3, coding for two zinc fingers) (2) . Although most classical effects of 1,25-(OH) 2 D 3 involve this genomic pathway, several other effects may be observed very rapidly, within seconds to minutes, and are not blocked by inhibitors of transcription or translation, suggesting a more direct action of the hormone at the membrane level (3) (4) (5) (6) (7) . These effects include activation of the phospholipase C pathway via G␣ q/11 (8, 9) , activation of the adenylate cyclase pathway (10) , opening of voltage-gated Ca 2ϩ channels (L-type) in the plasma membrane (11, 12) , Ca 2ϩ mobilization from the endoplasmic reticulum (5) , and an increase in cyclic guanosine monophosphate levels (13) . The rapid effects of 1,25-(OH) 2 D 3 also include the activation of the mitogenactivated protein kinase (MAPK) pathway (14 -16) , which induces a cross-talk with the cell nucleus via phosphorylation of cytoplasmic kinases and nuclear transcription factors (7, 16, 17) .
Attempts have been made to identify the receptor mediating the non-classical rapid effects of 1,25-(OH) 2 D 3 , but the data are still controversial (7, 18, 19) . A first set of data supports the hypothesis that VDR itself mediates 1,25-(OH) 2 D 3 rapid effects. Among those findings are the observations that functional VDR expression and rapid response to 1,25-(OH) 2 D 3 in enterocytes have a simultaneous onset during rat post-natal development (20) and that the generation of transgenic mice lacking the first zinc finger of the VDR blocks rapid and longterm responses of osteoblasts to 1,25-(OH) 2 D 3 (21) . But other data suggest that the presence of a functional nuclear VDR is not compulsory, as these findings showed persistent rapid effects of 1,25-(OH) 2 D 3 on protein kinase C (PKC) activation and Ca 2ϩ increase in osteoblasts of transgenic mice expressing a non-functional VDR lacking the second zinc finger and most of the ligand-binding domain (22) . Moreover, putative vitamin D membrane receptors that are different from the nuclear VDR, such as annexin II (23) and the recently identified membraneassociated rapid response steroid (MARRS) (24) , have been located on the external surface of the cell.
In an attempt to solve this dilemma, we tested rapid and long term effects of 1,25-(OH) 2 D 3 in dermal fibroblast cultures from three children with severe hereditary vitamin D-resistant rickets (HVDRR) and missense homozygous mutations of the VDR gene and from one age-matched child with no clinical and biological signs of vitamin D resistance. Cells from patient 1, with a K45E mutation in the DNA-binding domain, were selected as a model with no DNA binding or transactivation capacity of the VDR, based on the preliminary data obtained * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. with these cells and on an earlier report describing the consequences of the same mutation in another patient (25) . Cells from patients 2 and 3, with a W286R mutation in the ligandbinding domain, were selected as models with markedly destabilized ligand binding capacity, as shown by previous biological studies (26) and as suggested by x-ray crystal structure analysis of the mutated VDR. 2 In the three cases, the remaining portion of the VDR gene was normal, unlike in the previously reported osteoblast models, which bore large deletions of the VDR gene (21, 22) .
For the rapid effects of 1,25-(OH) 2 D 3 , we followed changes in intracellular calcium in Fura2-loaded cells, an effect observed within seconds and reported in a number of cell systems (5, 7). For long term effects, we evaluated the activity of the 24-hydroxylase, a key mitochondrial cytochrome P450 enzyme complex in the catabolism pathway of vitamin D (27) , as well as the mRNA expression of two of its components, CYP24 and ferredoxin. These enzyme activity and mRNA expressions are known to be markedly enhanced by 1,25-(OH) 2 D 3 (27) (28) (29) . Lastly, to determine precisely the mechanism underlying a possible association between rapid and long term effects, culture experiments have been performed in the presence or absence of verapamil, a blocker of Ca 2ϩ channels, or of PD98059, an inhibitor of the MEK 1/2-kinase (30) , which has been shown to inhibit induction of CYP24 gene expression by 1,25-(OH) 2 D 3 (31) .
Our results strongly support the hypothesis that VDR and especially the KGFFRR motif of its DNA-binding domain, including lysine 45, are required for the rapid effects of 1,25-(OH) 2 D 3 on intracellular calcium. They also suggest that part of the 1,25-(OH) 2 D 3 -induced stimulation of the 24-hydroxylase activity depends on these rapid effects via a calcium-and MAPK-dependent mechanism, leading to increased mRNA expressions of the CYP24 and ferredoxin genes.
EXPERIMENTAL PROCEDURES
Materials-Unlabeled 1,25-(OH) 2 D 3 was a gift from Hoffmann-La Roche, and unlabeled 24,25-(OH) 2 D 3 was a gift from Dr. Uskokovic (Hoffmann-La Roche). 25-(OH) [26,27- 3 H]D 3 (specific activity, 23 Ci/ mmol) was purchased from Amersham Biosciences. Chromatography solvents (n-hexane and isopropanol), methanol, and chloroform were purchased from Merck. Verapamil, nifedipine, U-73122, U-73343, and PD 98059 were purchased from Sigma-Aldrich.
Patient and Control Fibroblasts-Fibroblasts from the three hereditary vitamin D-resistant rickets patients were started from skin biopsies.
Patient 1, a girl aged 3 years and 6 months at the time of the skin biopsy, exhibited severe vitamin D-resistant rickets with complete alopecia (unpublished case). The sequencing data of this patient's VDR gene showed a missense mutation in the DNA-binding domain (lysine to glutamic acid at position 45, located in exon 2), a mutation identical to that reported by other authors (25) . Fibroblasts from this patient, as reported earlier (25) , had a normal ability to bind 1,25-(OH) 2 D 3 (affinity and number of binding sites) as compared with control fibroblasts.
Patient 2, a girl aged 7 months, and patient 3, her older brother aged 5 years and 7 months at the time of the skin biopsy, exhibited severe vitamin D-resistant rickets without alopecia (26) . Sequencing of the VDR gene in both patients showed a missense mutation in the ligandbinding domain (mutation of tryptophan to arginine at position 286, located in exon 7). The patients' dermal fibroblasts were unable to bind 1,25-(OH) 2 D 3 when tested at 25°C for 1 h or at 4°C overnight, but they expressed a normally sized VDR protein (immunocytochemistry and Western blotting) and VDR mRNA of normal length (Northern blotting). In addition, the VDR trafficking toward the nucleus did not seem to be affected in the patients' cells (26) .
Fibroblasts from an age-matched control were derived from skin sample collected during plastic surgery. This child, aged 2 years and 9 months, had no known alteration of calcium and bone metabolism.
Cell Culture-Control and patients' fibroblasts were grown at 37°C under a 5% CO 2 atmosphere in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen) supplemented with 10% fetal bovine serum, penicillin, streptomycin, and fungizone until confluent. The cells were then trypsinized and seeded on rectangular glass coverslips (3 cm 2 ) at a density of 60,000 cells for calcium assay or in 24-well culture plates at 5 ϫ 10 5 cells/well for 3 days in DMEM plus 10% fetal bovine serum for 24-hydroxylase activity and mRNA determinations. 3 24-Hydroxylase Assay-The fetal bovine serum was removed, and 1 ml of fresh serum-free medium was added for 1 h before adding non-radioactive 1,25-(OH) 2 D 3 (1 pM-10 nM) or its solvent (ethanol) for a further 18 h as described (32) . After rinsing with serum-free medium, 1.6 nM 25-(OH) [ 3 H]D 3 (0.05 Ci) were added, and the cells were incubated for an additional 120 min. The medium was removed, and the 3 H-labeled vitamin D3 derivatives present in the medium were extracted by adding 2 ml of methanol plus 2 ml of chloroform. The chloroform extract was co-chromatographed with 100 ng of unlabeled 24,25-(OH) 2 D 3 using a straight phase high pressure liquid chromatography system (Beckman, Berkeley, CA) equipped with a 4.6 ϫ 250-m Ultrasphere Si column (Altex, Berkeley, CA), and equilibrated with n-hexane-isopropanol (95:5) (flow rate, 1.5 ml/min). Absorbance at 254 nm was continually monitored, and effluent fractions were collected every minute. After evaporation to dryness, fractions were dissolved in Ultima Gold scintillation fluid (PerkinElmer Life Sciences), and the radioactivity was measured. In some experiments, verapamil (1 or 100 M) or PD 98059 (10 M) was added 1 h before the addition of unlabeled 1,25-(OH) 2 D 3 or its solvent. The 24-hydroxylase enzyme activity (fmol/ culture well/120 min) was calculated based on the percent of the injected radioactivity recovered in the 24,25-(OH) 2 D 3 region after high pressure liquid chromatography.
25-(OH)D
24-Hydroxylase Northern Blot Analysis-Total RNA was extracted from control and patients fibroblasts using the guanidium thiocyanatephenol-chloroform method of Chomczynski and Sacchi (33) . Samples of total RNA (30 g) were fractionated on 1.2% formaldehyde agarose gels and transferred to a nitrocellulose membrane by diffusion blotting for Northern blot analysis. The filters were baked at 80°C for 120 min in an oven. 24-hydroxylase mRNA levels were analyzed in control and patients' fibroblasts treated with 1 pM-10 nM 1,25-(OH) 2 D 3 or its solvent for 16 h. They were hybridized with a 32 P-labeled human 24-hydroxylase cDNA probe labeled by the random primer method (Rediprime, Amersham Biosciences). The human 24-hydroxylase cDNA (2.6 kb) was cloned in the pGEM 3Z plasmid (a gift from Prof. H. F. DeLuca). After hybridization, Northern blot autoradiograms were assessed by scanning densitometry (Gel Doc 2000, Bio-Rad). Glyceraldehyde-3-phosphate dehydrogenase was used as control for loading and transfer efficiency as it is unaffected by 1,25-(OH) 2 D 3 treatment.
24-Hydroxylase (CYP24) and Ferredoxin mRNA Analysis by Reverse Transcription (RT)-PCR-4
g of total RNA were reverse transcribed using Superscript TM II RNase H reverse transcriptase (Invitrogen) in a final volume of 25 l. 2 l of reverse transcription product was PCRamplified with human 24-hydroxylase primers (24 forward primer, 5Ј-GGT GAC ATC TAC GGC GTA CA-3Ј and 24 reverse primer, 5Ј-TTT AAA TAC GGC ATA TTC CTC AAA-3Ј) or with human ferredoxin primers (ferredoxin forward primer, 5Ј-TGA TTC TCT GCT AGA TGT TGT G-3Ј and ferredoxin reverse primer, 5Ј-TAT GAA GTC CAC TCA TCC ATG T-3Ј). PCR was performed using Taq polymerase (Appligene Oncor) with 0.16 M each primer in buffer containing 1.5 mM MgCl 2 and 2.5% Me 2 SO for 35 cycles. Each cycle consisted of denaturation at 95°C for 1 min, annealing at 59°C for 1 min, and primer extension at 72°C for 2 min with a final elongation step at 72°C for 10 min.
The mRNA of the human small ribosomal protein 14 (S14) was used as a steadily expressed internal control. Amplification was performed with forward and reverse S14 primers (5Ј-GGC AGA CCG AGA TGA ATC CTC A-3Ј (forward) and 5Ј-CAG GTC CAG GGC TCT TGG TCC-3Ј (reverse)), and carried out for 23 cycles. Each cycle consisted of denaturation at 95°C for 30 s, annealing at 55°C for 30 s, and primer extension at 72°C for 30 s.
The resulting PCR products (519-bp fragment for 24-hydroxylase and 397-bp fragment for ferredoxin) were resolved by electrophoresis in a 1% agarose gel, whereas the 144-bp fragment for S14 was resolved in a 2% agarose gel. DNA was blotted onto a Hybond-N nylon membrane (Amersham Biosciences) by alkaline transfer. Hybridization was carried out at 50°C in a high astringent solution containing the appropriate ␥-32 P-labeled oligonucleotide probe. The internal oligonucleotide probes had the following sequences: 5Ј-GCC ATG ATG AAG TTC ACA GC-3Ј (for 24 hydroxylase); 5Ј-TTT GGT GCA TGT GAG GGA AC-3Ј (for ferredoxin); and 5Ј-GAT GTA TAG GGC GGT GAT ACC CAG CTC CTT-3Ј (for S14). The autoradiography signals were analyzed with a densitometric scanner (BioRad Gel Doc 2000), and the results are expressed in arbitrary units as the ratio of 24-hydroxylase or ferredoxin to S14 densitometric values.
Calcium Measurement-Confluent fibroblasts were incubated for 24 h in a serum-free medium and assayed for intracellular calcium concentration ([Ca 2ϩ ] i ) as described (8) . In brief, cells were loaded with 1 M Fura-2/AM in Hanks' HEPES, pH 7.4 (137 mM NaCl, 5.6 mM KCl, 0.441 mM KH 2 PO 4 , 0.442 mM Na 2 HPO 4 , 0.885 mM MgSO 4 .7H 2 O, 27.7 mM glucose, 1.25 mM CaCl 2 , and 25 mM HEPES) for 30 min at room temperature. The glass coverslip carrying the cells was inserted into a cuvette containing 2.5 ml of Hanks' HEPES, pH 7.4, that is placed in a temperature-controlled (37°C) Hitachi F-2500 spectrofluorometer (Sciencetec-Braun, Les Ulis, France). Drugs and reagents were added directly to the cuvette under continuous stirring. The Fura-2 fluorescence response to the intracellular calcium concentration [Ca 2ϩ ] i was calibrated from the ratio of the 340/380 nm fluorescence values after subtraction of the background fluorescence of the cells at 340 and 380 nm. The dissociation constant for the Fura-2-Ca 2ϩ complex was taken as 224 nM (34) . The values for R max and R min were calculated from determinations with 25 M digitonin, 4 mM EGTA, and enough Tris base to raise the pH to 8.3 or higher. Each measurement on Fura-2-loaded cells was followed by a parallel experiment under the same conditions with cells not loaded with Fura-2. The [Ca 2ϩ ] i response to 10 pM-1 nM 1,25-(OH) 2 D 3 was studied in basal conditions or 120 s after the addition of one of the following compounds (each 1 M): verapamil or nifedipine (two selective blockers of L-type Ca 2ϩ channels), U-73122 (a direct inhibitor of phospholipase C linked to the hydrolysis of phosphatidylinositol 4,5 bisphosphate), or U-73343 (an inactive analog of U-73122).
Statistical Analysis-The data were subjected to an overall statistical evaluation using analysis of variance (ANOVA). Test groups were compared with respective untreated control groups using the Mann and Whitney non-parametric U test. 2 ] i within 5-10 s in Fura2-loaded fibroblasts derived from the control child, who had no disorder of calcium metabolism. The peak value was observed after 15 s, and a subsequent lower plateau phase persisted above basal level for more than 60 s (Fig. 1) . The 1,25-(OH) 2 D 3 effect on [Ca 2ϩ ] i peak value was dose-dependent and bell-shaped, with a maximum at 100 pM (Fig. 2) .
RESULTS

Rapid Effects of 1,25-(OH)
Fibroblasts (Fig. 3) . The use of nifedipine (1 M), another blocker of L-type Ca 2ϩ channels, gave similar results (data not shown). Adding 1 M U-73122, an inhibitor of phospholipase C linked to the hydrolysis of phosphatidyl-inositol 4,5 bisphosphate, for 120 s abolished the transient 1,25-(OH) 2 D 3 -induced peak (Fig. 3) . U-73343, its inactive analog, had no effect (data not shown). Both calcium channel blockers and U-73122 blocked the transient peak [Ca 2ϩ ] i response to 1,25-(OH) 2 D 3 in W286R fibroblasts as in controls (Fig. 3, data (Fig. 4) . 1,25-(OH) 2 D 3 , added 18 h before the enzyme assay, stimulated 24-hydroxylase activity in a dose-dependent manner with a significant 2-fold increase over base line at 1 pM up to a 9-fold increase at 10 nM. Fibroblasts bearing the K45E mutation (patient 1) showed no detectable 24-hydroxylase activity in basal conditions and did not respond to 1,25-(OH) 2 D 3 at concentrations ranging from 1 pM to 10 nM (Fig. 4) .
Fibroblasts bearing the W286R mutation (patient 2) were similar to controls as regards their basal production of 24,25-(OH) 2 D 3 and their response (2.5-fold increase) to the lowest (1 pM) 1,25-(OH) 2 D 3 concentration tested (Fig. 4) . But, unlike in controls, no further stimulation of 24-hydroxylase activity was observed with higher 1,25-(OH) 2 D 3 doses, and a barely significant 1.8-fold increase was observed with 10 nM.
Effect of Ca 2ϩ Channel Blockers on 24-Hydroxylase ActivityTreatment of control fibroblasts with 1 M verapamil significantly increased the basal 24-hydroxylase activity, whereas 100 M verapamil had no effect (Fig. 5) . Both verapamil treatments abolished the stimulatory effect of low (1 pM and 100 pM) doses of 1,25-(OH) 2 D 3 on 24,25-(OH) 2 D 3 production. But they did not significantly alter the effect of the highest (10 nM) 1,25-(OH) 2 D 3 dose (Fig.  5) . As in control cells, basal 24-hydroxylase activity was increased in W286R fibroblasts after 1 M verapamil pretreatment and unchanged after 100 M verapamil treatment (Fig.  5 ). In these patient cells, both verapamil treatments abolished the 1,25-(OH) 2 D 3 -induced stimulation of 24-hydroxylase activity in the dose range tested (1 pM-10 nM). (Fig. 6) but was detectable by RT-PCR (data not shown) in nuclear extracts from control fibroblasts cultured under basal conditions. This mRNA expression became detectable by both techniques 6 h after the addition of 1,25-(OH) 2 D 3 (100 pM) to the culture medium, and the highest levels were observed after 18 -24 h by Northern blot (24-hydroxylase/glyceraldehyde-3-phosphate dehydrogenase mRNA ratios) and RT-PCR (24-hydroxylase/S14 ratios) analyses. All tested doses (1 pM-10 nM) of 1,25-(OH) 2 D 3 were effective after 18 h, and a maximal effect was observed with 100 pM and 10 nM (Fig. 6) .
Effects of 1,25-(OH) 2 D 3 on 24-Hydroxylase (CYP24) mRNA Expression-24-hydroxylase mRNA expression could not be detected by Northern blots
No 24-hydroxylase mRNA expression could be detected by Northern blot, with or without 1,25-(OH) 2 D 3 (100 pM for 18 h), in fibroblast cultures derived from patients 1 and 2 (Fig. 6) . But RT-PCR analysis in cells from patient 2 showed a detectable CYP24 mRNA expression under basal conditions, a significant 2-fold increase 6 h after adding 100 pM 1,25-(OH) 2 D 3 (Fig. 7B) , and a fading 1,25-(OH) 2 D 3 -induced effect thereafter.
Effects of 1,25-(OH) 2 D 3 on Ferredoxin mRNA
Expression-In addition to CYP24, the mRNA expression of ferredoxin, another component of the 24-hydroxylase enzyme system, has been analyzed by RT-PCR in fibroblasts from control (data not shown) and patient 2 (Fig. 7C ). Results were similar to those relative to CYP24, with easily detectable mRNA expression in basal conditions in both cell types and a significant 1.6 -2.2-fold maximal increase after adding 100 pM 1,25-(OH) 2 D 3 for 18 (control cells) or 6 h (patient 2 cells). 
Blockage of the 24-Hydroxylase and Ferredoxin Responses to 1,25-(OH) 2 D 3 by Verapamil and PD 98059 -Simultaneous
DISCUSSION
Although numerous rapid effects of vitamin D have been observed in several cell systems, their mediation by the classical nuclear receptor of vitamin D or by an as yet putative cell membrane receptor is still debated (7, 18 -24) . Another open question relates to the physiological relevance of these rapid effects. Their possible role in the genomic control of cell differentiation, cell proliferation, and the regulation of CYP24, a catabolic and activating enzyme in the vitamin D endocrine system (27) , only begins to be unveiled (7, 31, 35) . The two current cell models bearing point mutations at key sites of the encoded VDR gene offer unique contributions to these challenging research fields. First, the current controversy over the presence and role of a distinct VDR membrane receptor is based on data obtained by different research teams using different cell models and different assays to test the rapid responses to 1,25-(OH) 2 D 3 (7, 18, 22) . In the present work, cell type, skin fibroblasts from agematched children, and culture conditions were identical, as was the biological test used for rapid 1,25-(OH) 2 D 3 response, namely modification of intracellular calcium in Fura-2-loaded cells. The main difference between the three cell models lay in the functionality of the VDR expressed by the cells, i.e. normal in the control cells bearing the wild type VDR or severely impaired in the fibroblasts bearing spontaneous homozygous point mutations in the DNA-binding domain (K45E) or in the ligand-binding domain (W286R).
Comparisons of the rapid responses to 1,25-(OH) 2 D 3 in the three models showed clear differences. Control cells responded within seconds to 1,25-(OH) 2 D 3 by increasing intracellular calcium concentration. The profile of the calcium response, the dose-response curve (maximal effect at 100 pM), and the inhibition of the response by the two L-type calcium channel blockers (verapamil and nifedipine) and the PLC inhibitor (U-73122) were identical to those found in other cell types such as osteoblasts, enterocytes, and parathyroid cells (7, 20, 21, 36) . Interestingly, fibroblasts bearing the K45E mutation showed no calcium response to 1,25-(OH) 2 D 3 , whereas fibroblasts bearing the W286R mutation showed a calcium response similar to controls as regards time course profile, the active range of 1,25-(OH) 2 D 3 concentrations, and the inhibitory effects of calcium channel and PLC inhibitors. In this latter cell model, the persistence of a rapid calcium response suggests that the substitution of the aromatic tryptophan residue (hydrophobic and neutral) by a non-aromatic arginine residue (hydrophilic and basic) still enabled 1,25-(OH) 2 D 3 binding for a time sufficient for rapid responses, whereas it abolished stable ligand binding (26) . In support of this hypothesis, data obtained after x-ray crystal structure analysis suggest that 1,25-(OH) 2 D 3 binding to the W286R-mutated VDR, although markedly destabilized, cannot be completely excluded. (30 g ) was loaded on denatured gel agarose 1% for size fractionation and transferred to a nitrocellulose membrane for Northern blot analysis. The blots were hybridized with a 32 P-labeled human 24-hydroxylase probe as described under "Experimental Procedures." The same filters were stripped and rehybridized to a glyceraldehyde-3-phosphate dehydrogenase (G3PDH)-cDNA probe as a control for RNA loading and transfer. membrane receptor(s) produced via a mechanism involving the transcriptional activity of nuclear VDR, as was proposed recently (7). Yet, this second hypothesis, although compatible with the data obtained in K45E cells, is not supported by our experiments with W286R fibroblasts, which show a clear dissociation between rapid calcium response to 1,25-(OH) 2 D 3 similar to controls and deficient transcriptional activity on the 24-hydroxylase gene.
As a third possibility, the nuclear VDR itself or another transcript of the VDR gene may interact locally with putative membrane receptor(s) or directly mediate the rapid effects of 1,25-(OH) 2 D 3 on intracellular calcium in human skin fibroblasts. In agreement with this hypothesis, other steroid hormone receptors have been reported to interact with cytoplasmic molecules and mediate rapid effects of the steroids. For example, binding of the estradiol receptor ␣ to the p85␣ regulatory subunit of phosphatidylinositol-3-OH kinase may mediate rapid effects of estrogens on endothelial nitric oxide synthesis (37) . Likewise, direct interaction of the progesterone receptor with SH3 domains of cytoplasmic signaling molecules may elicit a rapid activation of c-Src tyrosine kinases and MAPKs (38) . If such is the case for the vitamin D system, the present data suggest that the involved VDR should include an intact lysine at position 45. As shown earlier, lysine 45 is located on the hydrophilic side of the sequence recognition helix, and substitution of lysine 45 to glutamic acid severely impairs VDR interactions with vitamin D DNA-responsive elements (25) . Most important, lysine 45 is a key amino acid at the beginning of the KXFF(K/R)R motif present in the DNA-binding domains of all known members of the steroid hormone receptor family (39) . Interactions at the nuclear level between this motif and calreticulin, an ubiquitous calcium-binding/storage protein, inhibit VDR binding to DNA and its transcriptional activity (40) and slow down its nuclear export (41) . It is conceivable that calreticulin/VDR interactions take place in other subcellular compartments aside from the nucleus and especially in the endoplasmic reticulum (ER) where calreticulin is mainly located. Indeed, the ER compartment of rat osteosarcoma (ROS) 17/2.8 cells binds calcitriol-occupied VDR (42) , and colocalization of fluorescent calcitriol with ER, the Golgi complex, and microtubules has been evidenced in human skin fibroblasts (43) . Interactions between VDR and calreticulin outside the nucleus may be of crucial importance for the modulation of integrin-adhesive functions and integrin-mediated calcium signaling (44) as well as cell differentiation and proliferation, whether or not these responses require a cross-talk with the cell nucleus (7) .
Another debated question relative to the rapid effects of steroids concerns the physiological function, if any, of these effects. The observed clear differences in the calcium responses to 1,25-(OH) 2 D 3 of the two mutated cell types offer the most valuable tools to search for the long term consequences of these rapid effects. At present, several rapid effects of 1,25-(OH) 2 D 3 have been reported on intracellular calcium entry and distribution, on the opening of Ca 2ϩ and Cl Ϫ channels, and on protein kinase C, MAPK, phospholipase A2, phospholipase C-␤1, and G␣q/11 activation (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . These rapid effects are thought to be involved in the process of cell proliferation/differentiation but also in vitamin D metabolism and catabolism via a MAPK-mediated stimulation of 25-(OH)D 3 -24-hydroxylase gene expression (7, 31) . The comparison of rapid and long term responses to 1,25-(OH) 2 D 3 in our two cell models strongly support the latter hypothesis as they show the following: (i) a parallelism between rapid calcium and long term 24-hydroxylase responses to low 1,25-(OH) 2 D 3 doses (1 pM to 100 pM) absent in K45E fibroblasts and present in W286R cells; (ii) a parallelism between 1,25-(OH) 2 D 3 effects on 24-hydroxylase activity and CYP24 mRNA expression, no effect in K45E cells, and 2-fold increases in W286R cells; and (iii) the blockage of these effects by PD98059, an inhibitor of the MEK 1/2 kinase. The present data also add new levels of complexity in our understanding of the 1,25-(OH) 2 D 3 mediated regulation of 24-hydroxylase activity in that 1,25-(OH) 2 D 3 not only increased CYP24 mRNA but also ferredoxin mRNA levels in control and W286R fibroblasts, and both effects were blocked by verapamil, suggesting a calcium-dependent regulation of the mRNA expression and/or stability of both genes. Taken together, these findings suggest that 1,25-(OH) 2 which, in turn, control CYP 24 and ferredoxin gene expressions (or mRNA stabilities). The two latter levels of regulation, which only require low levels of 1,25-(OH) 2 D 3 , may serve a regulatory function by allowing rapid cell adaptation to rapid changes in intracellular calcium concentration.
Finally, one may wonder whether the persistence or nonpersistence of rapid responses to 1,25-(OH) 2 D 3 should affect the severity of the vitamin D resistance in patients bearing VDR mutations. In the present case, both W286R and K45E patients had very severe resistance to vitamin D, requiring calcium infusions, whereas their fibroblasts exhibited a persistent rapid response or an absence thereof to 1,25-(OH) 2 D 3 . These observations may, at first, be surprising if rapid effects of 1,25-(OH) 2 D 3 play a major role in, for example, cell proliferation/differentiation. But the severe deficit in calcium absorption and hypocalcemia resulting from the two mutations may themselves be deleterious, as was clearly shown in patients receiving calcium infusions and in VDR knock-out mice given a high calcium rescue diet (1) . Of interest, one of the possible consequences of this calcium deficiency may be to decrease calreticulin expression and decrease calcium mobilization from intracellular pools, two alterations observed in vitamin Ddepleted rats (48) .
In conclusion, the comparison of rapid and long-term responses to 1,25-(OH) 2 D 3 in three fibroblast models expressing normal, W286R-mutated, or K45E-mutated VDR provides evidence that the rapid effects of 1,25-(OH) 2 D 3 on intracellular calcium require the presence of the classical vitamin D receptor and especially of lysine 45 in the KGFFRR motif of the DNAbinding domain. These rapid effects control, in part, the first step of 1,25-(OH) 2 D 3 catabolism via calcium and MEK 1/2 kinase pathways leading to increased mRNA expression of the CYP24 and ferredoxin genes in the 24-hydroxylase complex.
